Skip to content

GLLife and health insurance

Globe Life

By

Updated

Not investment advice. Kevin may own this stock. How we value stocks

History
Price
$151.66
Intrinsic value
Intrinsic value from an AI estimate
Discount category
Below intrinsic value (AI estimate)
Analysts
Leaning bullish
Next earnings
Jan 21 · · estimated
Pick status
Research only

In short

Thesis
The market doubts Globe Life after the short seller reports, the class action and new health losses at United American, and 2027 earnings within its guidance with lower health losses can lift its value.
Gap
Can close. The Q4 2026 results and 2027 results show if losses at United American stop and if Globe Life meets its 2027 guidance, and the class action can end with a ruling or a settlement.

Company guidance: 2027 net operating income per share of $16.10 to $17.10; 2026 of $15.35 to $15.65; 2026 buybacks of $725 to $775 million (, Q3 2026 earnings release (8-K))

Price history

About

Globe Life Inc. (GL) sells basic life insurance and supplemental health insurance to middle-income families in the United States. It sells through exclusive agencies: American Income Life, which focuses on union and credit union members, Liberty National and Family Heritage. It also sells directly to consumers by mail, phone and online, and through the independent United American agency, which sells Medicare Supplement and, through Evry Health, group health insurance.

Life insurance was 66% of premium revenue and 80% of the insurance underwriting margin in Q3 2026. Total premium was $3.88 billion in the first nine months of 2026. Globe Life reports in US dollars, and its shares trade on the NYSE.

Thesis

The market prices Globe Life with doubt since April 2024, when short seller reports made claims about the practices of its agencies. A securities class action and several shareholder derivative suits, which come in part from those reports, are still open, and the plaintiffs moved for class certification in May 2026. In Q3 2026, losses at Evry Health and a claims processing delay at the Centers for Medicare and Medicaid Services also caused an underwriting loss at United American, and Globe Life cut its 2026 guidance. The AI estimate uses a multiple of the 2027 net operating income per share that the company guides to.

For the price to rise, three things must be true. Globe Life must earn 2027 net operating income per share within its guidance of $16.10 to $17.10. United American must return to an underwriting profit as Evry raises prices and selects risks more carefully. The class action and the derivative suits must end without a large payment.

The Q4 2026 results, expected about January 21, 2027, are the next test, and the 2027 results show the trend over the next four quarters. If health losses grow, agent counts fall or a court rules against the company, the price can fall.

Valuation

AI estimate, checked by Kevin. How it is made

Show the method

The intrinsic value for Globe Life is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of Globe Life. The method is a multiple of net operating income per diluted share for 2027.

Net operating income is the company's own measure. It leaves out realized investment gains and losses, legal proceedings and some other items, and it is after interest, stock compensation and tax. The Q3 2026 results (Form 8-K of October 21, 2026) give net operating income of $4.84 per diluted share for Q3 2026, which includes a gain of $120.5 million before tax from the annual update of reserve assumptions. The Q1 and Q2 2026 results give $3.43 and $3.61 per share, so the first nine months were $11.88 per share.

The Q3 2026 results give 2026 guidance of $15.35 to $15.65 per share and 2027 guidance of $16.10 to $17.10 per share. They also give book value per share without accumulated other comprehensive income of $103.62 at September 30, 2026. Because net operating income is after interest, the estimate makes no separate debt adjustment. The Form 10-Q gives debt with a par value of $3,019 million at September 30, 2026.

The cover of the Form 10-Q gives 75,439,736 shares of common stock at October 30, 2026, and the estimate uses the per diluted share figures of the company. The 2027 net operating income per share and the multiples are assumptions. The low case assumes $15.60 per share, below the guidance, because losses at United American continue and lapses rise, at 8 times. It gives $124.80 per share.

The base case assumes $16.50, near the middle of the guidance, at 10.5 times. It gives $173.25 per share. The high case assumes $17.10, the top of the guidance, at 12 times. It gives $205.20 per share.

The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $169.13 per share. Globe Life sells small basic life and supplemental health policies to middle-income families through its own exclusive agencies and by direct mail and online. Its life underwriting margin was 53% of premium in Q3 2026, and the company has kept high margins for many years.

Its agency systems are costly to build, and its policies stay in force for many years. These give an advantage that can last 10 years or more. But other insurers can sell similar policies, and the company must recruit new agents all the time. The estimate uses no results after September 30, 2026.

Checkpoints

  1. Jan 21, 2027 · est.Pending
    Q4 2026 results: health margins and 2026 earningsNet operating income for 2026 is within $15.35 to $15.65 per share and United American has an underwriting profit in Q4 2026, and this passes; a lower result or another underwriting loss fails.
  2. 2027 · est.Pending
    Securities class actionThe court denies class certification or the case ends without a material payment, and this passes; class certification or a large settlement fails.

Every passed and failed checkpoint across all picks

Recent events

  • November 4, 2026The Board adopted amended by-laws. The lead independent director can now call special meetings of the Board, and the Compensation Committee now sets the pay only of executive officers.
  • October 21, 2026Globe Life reported Q3 2026 results. Net operating income was $4.84 per diluted share, against $4.81 a year earlier, and total premium grew 7%. United American had an underwriting loss because of high-severity claims at Evry and a claims processing delay at the Centers for Medicare and Medicaid Services. Globe Life lowered its 2026 guidance to $15.35 to $15.65 per share and gave 2027 guidance of $16.10 to $17.10 per share.
  • August 6, 2026Globe Life raised its quarterly dividend by 22% to $0.33 per share, and the Board authorized up to $2.5 billion under the share repurchase program.
Show 4 older events
  • July 22, 2026Globe Life reported Q2 2026 results. Net operating income was $3.61 per diluted share, 10% more than a year earlier, and it raised its 2026 guidance to $15.55 to $15.95 per share.
  • June 26, 2026Globe Life amended its $1 billion credit facility, which now matures in 2031, and increased its term loan from $250 million to $450 million, with maturity extended to June 2029.
  • April 22, 2026Globe Life reported Q1 2026 results. Net operating income was $3.43 per diluted share, 12% more than a year earlier, and it raised its 2026 guidance to $15.40 to $15.90 per share.
  • February 4, 2026Globe Life reported 2025 results. Net operating income was $14.52 per diluted share, against $12.37 in 2024.

Latest news and filings

Last earnings
October 21, 2026 (8-K on sec.gov)
Next earnings
Expected about January 21, 2027. The company has not confirmed the date.

Every filing on SEC EDGAR (CIK 320335)

Risks

  • A securities class action for the period from May 2019 to April 2024 and several shareholder derivative suits are open. They come in part from short seller reports about the agencies. The plaintiffs moved for class certification in May 2026, and the company cannot estimate the amount of a loss.
  • Evry Health, a young group health business, caused an underwriting loss of $26 million in the first nine months of 2026, and its results can stay volatile while it grows.
  • Growth depends on the number of agents. The average producing agent count at American Income fell 7% in Q3 2026 from a year earlier.
  • Medicare Supplement claims and medical cost trends are rising, and the company needs regulators to approve premium rate increases on health policies.
  • Changes in interest rates move the fair value of the bond portfolio, which had a net unrealized loss of $2,687 million at September 30, 2026, and change the yield on new investments.

Key statistics

Market cap
$11B
Shares of Oct 30, 2026
Yield at current rate
0.9%
Current annual rate, at the price of Nov 20, 2026
Dividend yield
0.8%
Last 12 months, at the price of Nov 20, 2026
P/E (trailing)
10.2
Price of Nov 20, 2026
EPS (trailing)
$14.94
12 months to Sep 30, 2026
52-week range
$129.21 – $191.55
To Nov 13, 2026
Beta
0.47
Vs S&P 500, 5 years monthly, to Oct 30, 2026
Average volume
501K
3 months, to Nov 13, 2026

Balance sheet

Cash
$353M
Debt
$3.0B
Net debt
$2.7B

Cash against debt

Cash$353M
Debt$3.0B

debt covered by cashnet debt $2.7B

When the debt is due

12 months$319M
Later$2.7B

The last debt is due in 2061.

At September 30, 2026, Globe Life had cash and short-term investments of $353 million and total debt with a par value of $3,019 million. Long-term debt was $2,700 million: senior notes due 2028 to 2034, junior subordinated debentures due 2057 and 2061, and a $450 million term loan due 2029.

Dividends

Yield at the current rate
0.9% (current annual rate, at today’s price)
Dividend yield
0.8% (last 12 months, at today’s price of $151.66)
Paid per share
$1.26 in the last 12 months (4 payments)
Current annual rate
$1.32 ($0.33 × 4 a year)
Payout ratio
7% of the last fiscal year’s earnings (the year that ended December 31, 2025)
Latest ex-dividend date
October 5, 2026, $0.33 per share

Dividends per share by year

Globe Life dividends per share by year
2016
$0.555
2017
$0.59
2018
$0.63
2019
$0.679
2020
$0.737
2021
$0.782
2022
$0.822
2023
$0.883
2024
$0.945
2025
$1.05

From 2020 to 2025, the dividend grew by about 7.3% a year. From 2016 to 2025, the dividend grew by about 7.3% a year.

Source: company filings and market data, read on November 13, 2026. The ex-dividend date is the first day a buyer no longer gets the next payment.

Questions about Globe Life

What does Globe Life do?

Globe Life Inc. (GL) sells basic life insurance and supplemental health insurance to middle-income families in the United States. It sells through exclusive agencies: American Income Life, which focuses on union and credit union members, Liberty National and Family Heritage. Its market cap is $11B at the current price of $151.66.

When does Globe Life report earnings next?

This is an estimate: Globe Life may report on January 21, 2027. It last reported results on October 21, 2026.

Is Globe Life stock below its intrinsic value?

Globe Life stock is below intrinsic value. The source of the intrinsic value is: AI estimate. This is general information, not advice.

What changed recently at Globe Life?

The latest update is from November 4, 2026. The Board adopted amended by-laws.

What are the main risks for Globe Life?

A securities class action for the period from May 2019 to April 2024 and several shareholder derivative suits are open. Evry Health, a young group health business, caused an underwriting loss of $26 million in the first nine months of 2026, and its results can stay volatile while it grows. Growth depends on the number of agents.

How much debt and cash does Globe Life have?

At September 30, 2026, Globe Life had $3.0B of debt and $353M of cash.

Does Globe Life pay a dividend?

Yes. The current annual dividend of Globe Life is $1.32 per share. That is a dividend yield of 0.9% at the current price of $151.66. In the last 12 months, it paid $1.26 per share (0.8%). The latest ex-dividend date was October 5, 2026.

Similar companies

  • COOThe Cooper CompaniesShares: Regulation and courts, Weak consumer
    Intrinsic value
    Below intrinsic value
    Gap
    Can close
  • ABEVAmbevShares: Regulation and courts, Weak consumer
    Intrinsic value
    Well below intrinsic value
    Gap
    Can close
  • AXPAmerican ExpressShares: Regulation and courts, Weak consumer
    Intrinsic value
    Below intrinsic value
    Gap
    Can close
  • ULUnileverShares: Regulation and courts, Weak consumer
    Intrinsic value
    Close to intrinsic value
    Gap
    Can close
  • ABGAsbury AutomotiveShares: Weak consumer, Regulation and courts
    Intrinsic value
    Well below intrinsic value
    Gap
    Can close

Loading your notes…

Read it all? Star GL or pass, then go on to the next one.